SYMPOSIA

Poster Presentations
had no treatment up to then, and stayed in prison for three years due to injuring his chief with a knife because of delusions of persecution.
Autism, flattening of affect, incoherent speech and bizarre, somatic, nihilistic delusions were found in the psychiatric examination.
Flupentixol decanoate 20 mg every 15 days IM, haloperidol 20 mg/day and biperiden 10mg/day were administered first IM then orally.
There was no remission even after adding ECT for ten sessions. Then clozapine was begun at 25mg/day and titrated to 500mg/day. He
was discharged with symptoms which were much improved by using clozapine 500 mg/day, haloperidol 10 mg/day, biperiden 4mg/day,
quetiapine 300 mg/day.
In this paper a schizophrenic patient with testicular mutilation was presented and genital amputation was discussed along with reports
in the literature.
Key words: Schizophrenia, testicular mutilation
Bulletin of Clinical Psychopharmacology 2011;21(Suppl. 2):S133-4
[PP-022] Ref. No: 135
Hoarding and mood disorder: A case report
Özlem Çetinkaya Girit 1 , Fulya Maner 1 , Emine Kılınç 2 , Derya İpekçioğlu 1 , Mehmet Emin Ceylan 1
1 Psychiatry Unit, Bakırköy Nueropsychiatry Research & Training Hospital, Istanbul-Turkey
2NPİ Nueropsychiatric Hospital , İstanbul
E-mail: fmaner@ttmail.com
Hoarding is the excessive acquisition of possessions and failure to use or discard them even if the items are worthless or hazardous. The
hoarder may believe that the hoarded items are very valuable, know that the accumulated items are useless, or attach a strong personal
value to items. It is not clear whether hoarding is an isolated disorder or rather a symptom of another condition such as obsessive
compulsive disorder. Hoarding seems to involve some neurological mechanisms which are detected by brain imaging studies. In this case
report a patient with mood disorder whose predominant symptom was hoarding is presented and the status of literature about hoarding
is reviewed.
Key words: Hoarding, obsessive compulsive disorder, mood disorder, dementia
Bulletin of Clinical Psychopharmacology 2011;21(Suppl. 2):S134
[PP-023] Ref. No: 140
Effect of fish oil on treatment of premenstrual syndrome
Mandana Zafari, Azar Aghamohammadi
Department of Midwifery Group, Islamic Azad University, Sari Branch, Sari, Iran
E-mail: mandanazafari@iausari.ac.ir
Objective: Women go through many hormonal changes throughout their lives from birth to death and this causes many physical and
mental challenges that are directly related to their unique reproduction delicacy. Premenstrual syndrome refers to a cyclic appearance of
somatic and psychiatric symptoms in some women. Different theories and hypotheses have been proposed and discussed on this issue.
Finding an effective and safe solution for the treatment of PMS has always been under consideration. The purpose of our study was to
determine the effect of fish oil on treatment of premenstrual syndrome.
Methods: This study was a double blind randomized placebo controlled trial. All of the medical students at the Medicine School of
Mazandaran filled in the Rosignol Bonlender Questionnaire for 3 months. This questionnaire included demographic information, inclusion
and exclusion criteria, check paper and the symptom list of Rosignol Bolender. A total of 200 girls suffering from the moderate and severe
forms of this syndrome were selected randomly and assigned in two groups. The first group (100 girls) took a 1000 mg /day capsule of fish
oil for all days of their cycle and the second group (100 girls) took placebo for all days of their cycle. The duration of this treatment was 3
months. After treatment, the severity of physical, mental, and combined physical-mental symptoms were compared before and after the
intervention. Also the comparison after intervention was done in two groups.
Results: Based on this and based on the independent sample test, these two groups were homogeneous from the point of view of age
(p = 0.287, based on independent sample test ), education level (p = 0.954, based on x2 tests), length of menstrual cycle (p = 0.305),
based on independent sample test ), severity of physical symptoms before intervention ( p = 0.039 ), severity of mental symptoms before
S134 Bulletin of Clinical Psychopharmacology, Vol: 21, Supplement: 2, 2011 - www.psikofarmakoloji.org